The global ultrasound devices market, estimated at USD 6.76 billion in 2023, is anticipated to grow at a CAGR of 6.82% from 2024 to 2030, reaching approximately USD 10.05 billion by the end of the forecast period. The market’s upward trajectory is attributed to the growing incidence of chronic diseases such as cardiovascular and urological disorders, continuous technological innovation, increasing awareness around early diagnosis, and a rising aging population vulnerable to chronic illnesses. Moreover, the growing preference for ultrasound imaging—owing to its non-radiative nature—is further accelerating market adoption.
DelveInsight’s Ultrasound Devices Market Insights report offers an in-depth assessment of current and forecasted market trends, company market shares, key growth drivers and challenges, as well as a comprehensive overview of leading players shaping the global ultrasound devices landscape.
Request for a sample page report @ https://www.delveinsight.com/report-store/ultrasound-devices-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
Key Takeaways from the Ultrasound Devices Market Report
The Ultrasound Devices market is expected to witness steady growth at a moderate CAGR between 2025 and 2032. According to DelveInsight’s analysis, North America is projected to lead the global Ultrasound Devices market throughout the forecast period.
Key industry participants include General Electric Company, FUJIFILM Sonosite Inc., Siemens Healthcare GmbH, Koninklijke Philips N.V., Canon Medical Systems Corporation, ESAOTE SPA, Mindray DS USA Inc., DRAMIŃSKI S.A., Konica Minolta Inc., Clarius Mobile Health Corp., TELEMED UAB, MedGyn Products Inc., Quantel Medical, Xuzhou Kaixin Electronic Instrument Co. Ltd., Promed Technology Co. Ltd., Shantou Institute of Ultrasonic Instruments Co. Ltd., SHENNONA Co. Ltd. (COMPAL), Shenzhen Lanmage Medical Technology Co. Ltd., Shenzhen Ricso Technology Co. Ltd., and SonoScape Medical Corp., among others.
Recent industry developments include:
-
November 13, 2024: SonoMotion received FDA de novo clearance for its Stone Clear™ device, designed to non-invasively move and clear kidney stone fragments using external ultrasound pulses—offering treatment without surgery or anesthesia.
-
November 15, 2021: TELEMED Medical Systems unveiled its MicrUs Pro Handheld USB Ultrasound at MEDICA 2021, marking a milestone as the first open-architecture, PC-based diagnostic ultrasound platform.
-
August 24, 2021: Israel-based DiA raised USD 14 million to enhance its AI-powered ultrasound analysis portfolio, expand partnerships, and strengthen its presence across multiple global regions.
-
July 14, 2021: CoapTech secured CE mark approval and a CPT procedure code for its PUMA-G ultrasound gastrostomy system, supporting its clinical adoption in international markets.
To read more about the latest highlights related to the Ultrasound Devices market, get a snapshot of the key highlights entailed in the Global Ultrasound Devices Market Report
Ultrasound Devices Overview
Ultrasound devices are diagnostic imaging tools that utilize high-frequency sound waves to generate real-time visuals of internal organs and tissues. Their non-invasive nature, lack of ionizing radiation, and ability to provide instant imaging results make them essential across multiple medical specialties such as cardiology, radiology, obstetrics and gynecology, urology, and musculoskeletal medicine.
The technology spans from large, cart-based systems designed for hospitals to portable and handheld models tailored for point-of-care use. Modern ultrasound systems increasingly incorporate AI-driven image analysis, 3D/4D imaging, Doppler functions for assessing blood flow, and wireless connectivity to enable efficient data sharing and remote diagnostics.
Market growth is primarily driven by the rising incidence of chronic conditions, increased emphasis on early disease detection, continuous technological progress, and the expanding elderly population. Additionally, ultrasound’s excellent safety profile—particularly for repeated use—along with its widening applications in diagnostic and therapeutic procedures, continues to boost adoption.
The competitive landscape remains innovation-focused, with leading players developing compact, user-friendly, and AI-enabled systems, as well as specialized probes for targeted clinical uses. Continuous regulatory approvals, strategic collaborations, and sustained R&D investments are further propelling steady growth within the global ultrasound devices market.
Ultrasound Devices Market Insights
North America is expected to dominate the global ultrasound devices market, supported by factors such as the increasing burden of chronic diseases—including cardiovascular disorders and cancer—rapid technological innovation, heightened awareness of early disease detection, an expanding elderly population, and a growing number of product launches across the U.S.
The region’s market growth is further strengthened by high disposable income levels, a well-developed healthcare infrastructure, and strong public awareness regarding disease management and prevention. According to the World Health Organization (WHO, 2021), non-communicable diseases (NCDs) are responsible for approximately 41 million deaths each year, accounting for 71% of global mortality. Additionally, the U.S. Centers for Disease Control and Prevention (CDC) estimates that by 2030, the incidence of new cancer cases will rise by 24% in men and 21% in women.
Consequently, the growing reliance on ultrasound devices for diagnostic applications across the U.S. is expected to significantly drive market demand, fostering a strong growth outlook for the North American ultrasound devices market.
To know more about why North America is leading the market growth in the Ultrasound Devices market, get a snapshot of the Ultrasound Devices Market Outlook
Ultrasound Devices Market Dynamics
The demand for ultrasound devices is steadily increasing, primarily due to the escalating global prevalence of chronic diseases such as cancer and HIV.
According to World Health Organization (WHO) data from 2022, there were approximately 2.26 million breast cancer, 2.21 million lung cancer, 1.93 million colorectal cancer, 1.41 million prostate cancer, and 1.09 million stomach cancer cases worldwide in 2020. Similarly, Globocan 2020 reported 1.41 million new prostate cancer cases that year, with projections indicating a rise to nearly 2.24 million cases by 2040.
Another significant contributor to market growth is the rapidly aging global population. As per WHO, around one billion people were aged 60 years or older in 2020, a number expected to double to 2.1 billion by 2050. Meanwhile, the population aged 80 years and above is forecasted to triple to 426 million within the same period. Since aging increases susceptibility to numerous health issues—including bone and spinal injuries, skeletal disorders, and osteoporosis—this demographic trend will likely expand the patient base for chronic diseases.
As a result, the use of ultrasound devices for disease diagnosis, monitoring, and management is anticipated to rise significantly, driving consistent market growth throughout the forecast period.
Ultrasound Devices Market Drivers:
-
Growing prevalence of chronic diseases
-
Continuous technological innovations enhancing product portfolios
Get a sneak peek at the Ultrasound Devices market dynamics
Scope of the Ultrasound Devices Market Report:
-
Coverage: Global
-
Study Period: 2022 to 2032
-
Key Ultrasound Devices Companies: General Electric Company, FUJIFILM Sonosite Inc., Siemens Healthcare GmbH, Koninklijke Philips N.V., Canon Medical Systems Corporation, ESAOTE SPA, Mindray DS USA Inc., DRAMIŃSKI S. A., Konica Minolta Inc., Clarius Mobile Health Corp., TELEMED UAB, MedGyn Products Inc., Quantel Medical, Xuzhou Kaixin Electronic Instrument Co. Ltd., Promed Technology Co. Ltd., Shantou Institute of Ultrasonic Instruments Co. Ltd., SHENNONA Co. Ltd. (COMPAL), Shenzhen Lanmage Medical Technology Co. Ltd., Shenzhen Ricso Technology Co. Ltd., SonoScape Medical Corp., and others.
Which MedTech key players in the Ultrasound Devices market are set to emerge as the trendsetter, explore @ Ultrasound Devices Companies
About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.
Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/